Boston Scientific Corp (BSX)
83.62
-0.40
(-0.48%)
USD |
NYSE |
Nov 01, 16:00
83.63
+0.01
(+0.01%)
After-Hours: 20:00
Boston Scientific Debt to Equity Ratio: 0.5187 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.5187 |
| March 31, 2024 | 0.5327 |
| December 31, 2023 | 0.4718 |
| September 30, 2023 | 0.471 |
| June 30, 2023 | 0.4964 |
| March 31, 2023 | 0.5042 |
| December 31, 2022 | 0.5081 |
| September 30, 2022 | 0.4863 |
| June 30, 2022 | 0.5196 |
| March 31, 2022 | 0.5557 |
| December 31, 2021 | 0.5448 |
| September 30, 2021 | 0.5514 |
| June 30, 2021 | 0.5708 |
| March 31, 2021 | 0.5779 |
| December 31, 2020 | 0.5957 |
| September 30, 2020 | 0.5991 |
| June 30, 2020 | 0.6096 |
| March 31, 2020 | 0.7477 |
| December 31, 2019 | 0.7203 |
| September 30, 2019 | 1.120 |
| June 30, 2019 | 1.010 |
| March 31, 2019 | 0.9972 |
| December 31, 2018 | 0.8087 |
| September 30, 2018 | 0.795 |
| June 30, 2018 | 0.8333 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.8151 |
| December 31, 2017 | 0.7955 |
| September 30, 2017 | 0.7487 |
| June 30, 2017 | 0.8064 |
| March 31, 2017 | 0.7818 |
| December 31, 2016 | 0.8145 |
| September 30, 2016 | 0.8369 |
| June 30, 2016 | 0.8725 |
| March 31, 2016 | 0.8792 |
| December 31, 2015 | 0.8983 |
| September 30, 2015 | 0.914 |
| June 30, 2015 | 0.7769 |
| March 31, 2015 | 0.6565 |
| December 31, 2014 | 0.6573 |
| September 30, 2014 | 0.6345 |
| June 30, 2014 | 0.6502 |
| March 31, 2014 | 0.6503 |
| December 31, 2013 | 0.6484 |
| September 30, 2013 | 0.6474 |
| June 30, 2013 | 0.6439 |
| March 31, 2013 | 0.6542 |
| December 31, 2012 | 0.6195 |
| September 30, 2012 | 0.6232 |
| June 30, 2012 | 0.5509 |
| March 31, 2012 | 0.3737 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.471
Minimum
Sep 2023
0.7477
Maximum
Mar 2020
0.5569
Average
0.5448
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.3764 |
| Baxter International Inc | 1.688 |
| Haemonetics Corp | 1.352 |
| ResMed Inc | 0.1304 |
| Masimo Corp | 0.571 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 37.11B |
| Total Liabilities (Quarterly) | 16.50B |
| Shareholders Equity (Quarterly) | 20.37B |
| Current Ratio | 1.612 |
| Net Debt Paydown Yield | 1.47% |